![]() |
Ch4 kinases. |
Clearer understanding about the markers and drivers of cancer cell proliferation has emerged from research that identifies new opportunities to overcome convergence with complex enzymes, known as kinases.
The work paves the way for new approaches to study the molecular drivers of disease states such as cancer.
Kinases are a specific family of proteins that add phosphates to other molecules – a process called phosphorylation, which can change the function of their substrates (target proteins). In humans, more than 500 kinases phosphorylate approximately 15% of all proteins. However, more than one kinase can phosphorylate the same substrate, and this can occur at the same or different sites. This is known as convergence, and can often make it difficult to study a specific kinase or substrate, as the activity of multiple kinases can hamper analysis.
Understanding the complex kinase network is important, as dysregulation of these proteins can drive disease, such as the survival and spread of cancer cells or their resistance to therapeutics.
While most kinase research has tended to focus on characterizing phosphorylation networks between kinases and their substrates, researchers in the Janovjak Lab at Flinders University’s College of Medicine and Public Health have taken a different tack by analyzing how common convergence is across all human kinases, and using these insights to dissect it experimentally.